K vs LAB · P/E 23, $29.03B cap vs rev $174.4M
Kellanova (K) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Kellanova (K) is a packaged foods company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
K does not have a complete income-statement cache yet.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
K currently screens at market cap $29.03B and trailing P/E 22.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the K and LAB stock pages for the full models.
Not investment advice.